Latest filing published 29 May 2026 for Gentian Diagnostics ASA, €17k. Read the official filing
Matti Heinonen discloses dealings in Gentian Diagnostics ASA to Oslo Børs. Between 16 December 2024 and 29 May 2026, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 29 May 2026: a transaction of €17k, in Gentian Diagnostics ASA. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations